NovaBay Pharmaceuticals Inc (NBY)
0.0821
0.00 (0.00%)
USD |
NYAM |
Apr 18, 16:00
0.0804
0.00 (0.00%)
After-Hours: 17:36
NovaBay Pharmaceuticals Gross Profit Margin (Quarterly): 48.70% for Dec. 31, 2023
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 48.70% |
| September 30, 2023 | 56.29% |
| June 30, 2023 | 50.02% |
| March 31, 2023 | 61.97% |
| December 31, 2022 | 48.17% |
| September 30, 2022 | 62.08% |
| June 30, 2022 | 50.19% |
| March 31, 2022 | 55.42% |
| December 31, 2021 | 52.88% |
| September 30, 2021 | 68.57% |
| June 30, 2021 | 71.21% |
| March 31, 2021 | 74.82% |
| December 31, 2020 | 56.94% |
| September 30, 2020 | 75.30% |
| June 30, 2020 | 48.80% |
| March 31, 2020 | 69.29% |
| December 31, 2019 | 65.20% |
| September 30, 2019 | 75.17% |
| June 30, 2019 | 77.47% |
| March 31, 2019 | 77.13% |
| December 31, 2018 | 87.83% |
| September 30, 2018 | 89.43% |
| June 30, 2018 | 82.86% |
| Date | Value |
|---|---|
| March 31, 2018 | 91.48% |
| December 31, 2017 | 84.53% |
| September 30, 2017 | 87.26% |
| June 30, 2017 | 83.07% |
| March 31, 2017 | 84.11% |
| December 31, 2016 | 80.18% |
| September 30, 2016 | 83.54% |
| June 30, 2016 | 82.01% |
| March 31, 2016 | 64.46% |
| December 31, 2015 | 63.85% |
| September 30, 2015 | 77.58% |
| June 30, 2015 | 74.90% |
| March 31, 2015 | 72.49% |
| December 31, 2014 | 39.51% |
| September 30, 2014 | 72.37% |
| June 30, 2014 | 85.37% |
| March 31, 2014 | 54.86% |
| December 31, 2013 | 84.31% |
| September 30, 2013 | 96.09% |
| June 30, 2013 | 98.11% |
| March 31, 2013 | 97.84% |
| December 31, 2012 | 99.28% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
48.17%
Minimum
Dec 2022
77.47%
Maximum
Jun 2019
61.50%
Average
61.97%
Median
Mar 2023
Gross Profit Margin (Quarterly) Benchmarks
| Eyenovia Inc | 0.00% |
| Palatin Technologies Inc | 95.20% |
| iBio Inc | -- |
| Theriva Biologics Inc | -- |
| Ampio Pharmaceuticals Inc | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -125.7% |
| Return on Assets | -69.74% |
| Return on Invested Capital | -114.9% |
| Profit Margin (Quarterly) | -110.2% |
| Operating Margin (Quarterly) | -21.41% |
| Return on Net Operating Assets | -105.0% |